Ergoteles’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,710
| Closed | -$665K | – | 556 |
|
|
2023
Q2 | $665K | Buy |
28,710
+1,074
| +4% | +$24.9K | 0.03% | 578 |
|
|
2023
Q1 | $642K | Buy |
27,636
+11,053
| +67% | +$257K | 0.03% | 651 |
|
|
2022
Q4 | $241K | Buy |
+16,583
| New | +$241K | 0.01% | 995 |
|
|
2022
Q3 | – | Sell |
-28,637
| Closed | -$520K | – | 1833 |
|
|
2022
Q2 | $520K | Buy |
+28,637
| New | +$520K | 0.02% | 820 |
|